Thank you for an informative article. This most certainly does sounds like a great buying opportunity. But I'm concerned that much of your buy recommendation comes from the assumption that the delay rumors are based on the misunderstanding of the methods
used for delivering RNA oligonucleotides. How can you be sure this was the reason? Can you please elaborate?
Latest Comments
Sarepta Tumbles On New Drug Data But Presents A Big Buying Opportunity
Sarepta Tumbles On New Drug Data But Presents A Big Buying Opportunity